These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 11807145

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Infections in neutropenic patients].
    Berenguer J.
    Enferm Infecc Microbiol Clin; 1995 Feb; 13(2):113-20. PubMed ID: 7711117
    [No Abstract] [Full Text] [Related]

  • 3. Empirical antifungal therapy for persistent fever in patients with neutropenia.
    Chandrasekar PH.
    Clin Infect Dis; 2001 Jan 15; 32(2):320-1. PubMed ID: 11170928
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Empirical antifungal therapy in selected patients with persistent febrile neutropenia.
    Aguilar-Guisado M, Espigado I, Cordero E, Noguer M, Parody R, Pachón J, Cisneros JM.
    Bone Marrow Transplant; 2010 Jan 15; 45(1):159-64. PubMed ID: 19525983
    [Abstract] [Full Text] [Related]

  • 6. Voriconazole versus liposomal amphotericin B in patients with neutropenia and persistent fever.
    Powers JH, Dixon CA, Goldberger MJ.
    N Engl J Med; 2002 Jan 24; 346(4):289-90. PubMed ID: 11807157
    [No Abstract] [Full Text] [Related]

  • 7. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Summary and comments.
    Sinkó J, Kullberg BJ, Edwards JE, Anaissie E.
    J Antimicrob Chemother; 2009 May 24; 63 Suppl 1():i41-3. PubMed ID: 19372182
    [No Abstract] [Full Text] [Related]

  • 8. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
    Klastersky J.
    J Antimicrob Chemother; 2009 May 24; 63 Suppl 1():i14-5. PubMed ID: 19372173
    [Abstract] [Full Text] [Related]

  • 9. Empiric treatment of fungal infections in the neutropenic host. Review of the literature and guidelines for use.
    Sugar AM.
    Arch Intern Med; 1990 Nov 24; 150(11):2258-64. PubMed ID: 2241435
    [Abstract] [Full Text] [Related]

  • 10. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
    Jarque I, Sanz MA.
    Enferm Infecc Microbiol Clin; 1999 Nov 24; 17 Suppl 2():95-102. PubMed ID: 10605194
    [Abstract] [Full Text] [Related]

  • 11. Management of persistent fever in the neutropenic patient.
    Bodey GP.
    Am J Med; 2000 Mar 24; 108(4):343-5. PubMed ID: 11014730
    [No Abstract] [Full Text] [Related]

  • 12. Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia.
    Przepiorka D, Buadi FK, McClune B.
    Pharmacotherapy; 2008 Jan 24; 28(1):58-63. PubMed ID: 18154475
    [Abstract] [Full Text] [Related]

  • 13. [Antibiotic strategy for febrile episodes during severe (less than 500 PNN) and prolonged (greater than or equal to 7 days) neutropenia. Recommendations of the Evaluation Committee of the Collège Français des Hematologistes].
    Cordonnier C, Leverger G, Schlemmer B, Andremont A, Boasson M, Herbrecht R, Kazmierczak A, Marie JP, Marit G, Miclea JM.
    Nouv Rev Fr Hematol (1978); 1994 Aug 24; 36(4):289-91. PubMed ID: 7971247
    [No Abstract] [Full Text] [Related]

  • 14. Empirical antifungal therapy--new options, new tradeoffs.
    Marr KA.
    N Engl J Med; 2002 Jan 24; 346(4):278-80. PubMed ID: 11807153
    [No Abstract] [Full Text] [Related]

  • 15. Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
    Ullmann AJ, Heussel CP, Cornely OA.
    N Engl J Med; 2002 May 30; 346(22):1745-7; author reply 1745-7. PubMed ID: 12041526
    [No Abstract] [Full Text] [Related]

  • 16. [Management of microbial infections in myeloid leukemia].
    Monma F, Katayama N.
    Nihon Rinsho; 2009 Oct 30; 67(10):1969-73. PubMed ID: 19860199
    [Abstract] [Full Text] [Related]

  • 17. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    Walsh TJ, Finberg RW, Arndt C, Hiemenz J, Schwartz C, Bodensteiner D, Pappas P, Seibel N, Greenberg RN, Dummer S, Schuster M, Holcenberg JS.
    N Engl J Med; 1999 Mar 11; 340(10):764-71. PubMed ID: 10072411
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.